INF904 Shows Strong Phase 2a Results in HS and CSU, With No Safety Signals
In a Phase 2a trial, INF904 demonstrated strong results for HS and CSU, with no safety signals reported. Early findings from this study suggest a potentially encouraging therapy option for these challenging conditions.
2 weeks ago
1 min read
